InvestorsObserver is giving Quoin Pharmaceuticals Ltd - ADR (QNRX) an Analyst Rating Rank of 74, meaning QNRX is ranked higher by analysts than 74% of stocks. The average price target for QNRX is $8 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating QNRX a Strong Buy today. Find out what this means to you and get the rest of the rankings on QNRX!